Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Bristol-Myers Squibb Company - ERBITUX® Supplemental Biologics License Application for Advanced Non-Small Cell Lung Cancer Submitted to U.S. Food and Drug Administration
DNA Vaccines - SARS Vaccine Achieves Neutralizing Responses in First U.S. Human Trial
Pacira Pharmaceuticals, Inc. - Positive Phase II Study of Pacira's EXPAREL DepoBupivacaine in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
Post Operative Pain - AcelRx Pharmaceuticals Reports Positive Results From a Phase 2 Clinical Trial of Sublingual Sufentanil NanoTabs(TM) in Treating Post-Operative Pain
Arthritis - Kaiser Permanente publishes research in arthritis
Breast Cancer - New breast cancer research reported from D.A. Yardley and co-authors
Gastric Cancer - New gastric cancer study findings have been reported from Kyushu University
Breast Cancer Clinical Trial - Research from College of Medicine, Department of Oncology in breast cancer clinical trial provides new insights
Breast Cancer Therapy - Researchers from Memorial Sloan Kettering Cancer Center describe findings in breast cancer therapy
Cancer Gene Therapy - University of Texas, M. D. Anderson Cancer Center publishes research in cancer gene therapy
Colon Cancer Therapy - Reports from University of Southern California, Norris Comprehensive Cancer Center describe recent advances in colon cancer therapy
Immunotherapy - Research conducted at Harvard University has provided new information about immunotherapy
Lymphoma Therapy - Investigators at Alfred Hospital zero in on lymphoma therapy
Monoclonal Antibodies - New findings from University of Texas, Health Science Center in the area of monoclonal antibodies described
Monoclonal Antibodies - Recent findings from M. Siano and co-authors highlight research in monoclonal antibodies
Prostate Cancer Therapy - New prostate cancer therapy data have been reported by scientists at Wayne State University, Karmanos Cancer Institute
Prostate Cancer Therapy - Researchers from Yale University, Department of Medicine provide details of new studies and findings in the area of prostate cancer therapy
Solid Cancer Therapy - Findings from University of Texas, Health Science Center broaden understanding of solid cancer therapy
Acne Vulgaris - Valeant to Acquire Dow Pharmaceutical Sciences, Inc. for $285 Million
Acute Myeloid Leukemia - Dacogen(R) (decitabine for injection) Data Presented on a Phase II Clinical Trial in Elderly Patients with Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia - Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology
Allos Therapeutics, Inc. - Allos Therapeutics Announces Top Line Results from Pivotal Phase 2 PROPEL Trial of Pralatrexate in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
Atrial Fibrillation - Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation
Atrial Fibrillation - New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation
B-Cell Lymphoma - Phase 2 Results of Rigel's R788 Show Clinical Benefit in Diffuse Large B-Cell Lymphoma and CLL
Cell Therapeutics, Inc. - Three Italian Multicenter Studies Report High (>70%) Rates of Complete Remission (CR) Utilizing Zevalin Radio-Immunotherapy (RIT) in Treatment of Newly Diagno
Clinical Trial Research - Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
Clinical Trial Research - Portola Pharmaceuticals Initiates Phase II Trial of Novel IV and Oral Anti-Platelet Drug in Non-Urgent Percutaneous Coronary Intervention
Flu Vaccines - USD 12.5 m Funding for the Development of Intercell's Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
Flu Vaccines - Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans
Hemoglobinuria - Alexion Reports Positive Results from AEGIS Registration Study of Soliris in Japanese Patients With PNH
Hepatitis C Virus - Human Genome Sciences Announces Albuferon(R) Meets Primary Endpoint in Phase 3 Trial in Chronic Hepatitis C
HIV/AIDS - Napo Pharmaceuticals Announces License of Crofelemer to Salix Pharmaceuticals
Immunization - Novavax Announces Top Line Results of Phase IIa Clinical Trial for Its Seasonal Influenza VLP (Trivalent) Vaccine Candidate
Leukemia - Celator(R) Pharmaceuticals Presents Phase 1 Results With CPX-351 in Patients With Advanced Leukemia at the American Society of Hematology Meeting
Malaria Vaccines - Two New Studies in the New England Journal of Medicine Show Malaria Vaccine Candidate Advancing in Africa
Myeloma - Novel VELCADE(R) (Bortezomib) for Injection Based Four-Drug Combination Was Well Tolerated In Previously Untreated Multiple Myeloma Patients
Myeloma - Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology
Pharmacokinetics - Nuvelo Announces Positive Results from Phase 1 Clinical Trial of NU206 in Healthy Volunteers
Pre-Trials Research - Proteolix Presents Preclinical Data for Oral Proteasome Inhibitor PR-047 at the 50th Annual Meeting of the American Society of Hematology
Reproductive Health - Agile Therapeutics Abstracts on Lead Product, AG200-15 Accepted by ACOG
Schizophrenia - AstraZeneca and Targacept Announce Top-Line Results from Phase IIb Study of AZD3480 in Cognitive Dysfunction in Schizophrenia
Schizophrenia - Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia
Surgery - Omeros Announces Results from a Phase 1 Study of OMS201 for Use During Urological Surgery
The Multiple Myeloma Research Foundation - Data from Eight Clinical Trials Facilitated by the Multiple Myeloma Research Consortium MMRC Presented at the American Society of Hematology ASH Annual Meeting
